What Arbro Pharmaceuticals does

Arbro Pharmaceuticals Pvt. Ltd. is a privately held Indian pharmaceutical contract development and manufacturing organisation (CDMO) and branded generics marketer, founded in 1985 and headquartered in New Delhi. The company operates a WHO-GMP, ISO 9001:2015, and Schedule M-certified manufacturing facility at Kirti Nagar, New Delhi, producing tablets, capsules (hard gelatin, HPMC, and soft gelatin), oral liquids, ointments and creams, dry syrups, soft gelatin capsules, nutraceuticals, herbal/Ayurvedic products, cosmeceuticals, and hand sanitizers across 13 therapeutic categories and 500+ SKUs. Its in-house R&D unit, recognised by India's Department of Science and Technology, holds a US patent on Self Nano Emulsifying Curcumin (SNEC30) developed in collaboration with DRDO and Jamia Hamdard, and operates alongside 5 ISO/IEC 17025:2017 accredited laboratories (2 USFDA-inspected, 1 WHO-prequalified) supporting both internal quality control and third-party testing.

Arbro makes money through two primary streams. Contract manufacturing accounts for the bulk of activity: 200+ pharmaceutical, nutraceutical, herbal, and cosmeceutical brand partners engage Arbro on a product-by-product basis with no minimum contract period, with services spanning formulation development, manufacturing, packaging, and regulatory dossier submission (CTD/eCTD, CDSCO, WHO PQ). Pricing is quote-based with 24–48 hour turnaround and MOQs ranging from 500 kg for creams to 2,000–5,000 litres for liquids. The secondary stream is own-branded generics and proprietary products (SNEC30 range, Vkap-D3, Azicin, Arlis-625, PLATI SOON, ARMEG 4G, Puritol sanitizers) distributed through authorised Indian distributors and stockists and exported to 30+ countries. Distribution is anchored by long-tenured client relationships (5–15 years typical) and supported by 350+ R&D scientists, partnerships with AIIMS, JNU, and Jamia Hamdard, and active participation in industry exhibitions such as IPHEX 2025.

The customer base is horizontally segmented across pharmaceutical brands, nutraceutical businesses, clinical research organisations, and cosmeceutical brands, served via a field-sales B2B motion (direct contact, phone, WhatsApp, website quote forms) and through authorised Indian distributors and stockists. Geographic reach is dual-shouldered: a domestic India core plus an export distribution arm into 30+ countries. Leadership is founder-led, with Vijay Kumar Arora as Founder/Owner and Saurabh Arora as Executive Director; ownership is private with no parent company, private equity, or venture capital backing disclosed in available sources.

Name

Arbro Pharmaceuticals

Legal name

Arbro Pharmaceuticals Pvt. Ltd.

Website

https://arbropharma.com

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

101–250 employees

Short description

Arbro Pharmaceuticals is a New Delhi-based WHO-GMP certified pharmaceutical CDMO and branded generics manufacturer, founded in 1985, serving 200+ pharmaceutical, nutraceutical, herbal, and cosmeceutical brand partners across India and 30+ export countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Specialty Care Pharmaceuticals (HLAIAAAB), Infectious Disease & Antimicrobials Pharmaceuticals (HLAIAAAG), Respiratory & Allergy Pharmaceuticals (HLAIAAAH)

Keywords

• Pharmaceutical contract manufacturing
• CDMO services
• Nutraceutical manufacturing
• Herbal ayurvedic manufacturing
• Cosmeceutical contract manufacturing

Headquarters

HQ city

New Delhi

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Contract Pharmaceutical Manufacturing: Manufacturing pharmaceutical, nutraceutical, herbal, and cosmeceutical products for other brands under contract manufacturing agreements. Handles formulation development, manufacturing, packaging, and regulatory submissions for client brands. No minimum contract period required, works on product-by-product basis.
2. Own Branded Pharmaceutical Products: Manufactures and markets own branded pharmaceutical products sold directly in Indian market and exported globally. Product range includes antibiotics, analgesics, anti-inflammatory, gastrointestinal, respiratory, vitamins & supplements, and proprietary SNEC30 curcumin range across 11 therapeutic categories.
3. Regulatory Affairs Services: Regulatory affairs department supports product registration across multiple countries. Services include CTD/eCTD dossier preparation, CDSCO approvals, WHO PQ dossiers, and export registrations for regulated and semi-regulated markets.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Arbro Pharmaceuticals is a WHO-GMP certified contract development and manufacturing organization (CDMO) and branded-generics marketer that produces tablets, capsules, oral liquids, ointments/creams, soft gelatin capsules, dry syrups, nutraceuticals, herbal/Ayurvedic formulations, cosmeceuticals, and hand sanitizers for 200+ brand partners across India and 30+ export countries. In parallel, it markets its own branded pharmaceutical products and proprietary Self Nano Emulsifying Curcumin (SNEC30) range, supported by in-house R&D, regulatory affairs, NABL-accredited analytical testing, and clinical research services.

Product overview

Arbro Pharmaceuticals is a WHO-GMP certified pharmaceutical contract manufacturer and marketer of branded pharmaceutical products, established in 1985 in New Delhi. The company operates as both a contract development and manufacturing organization (CDMO) and a branded generics company. Contract manufacturing services span tablet manufacturing, capsule manufacturing (hard gelatin and HPMC), liquid/syrup manufacturing, ointment and cream manufacturing, soft gelatin capsules, dry syrups and oral suspensions, nutraceutical manufacturing, herbal and Ayurvedic manufacturing (AYUSH compliant), cosmeceuticals, hand sanitizers, private label/OTC products, and full packaging solutions. The branded product portfolio includes antibiotics (AZICIN, ARLIS, CFR, FLOX-O, LEOAB, NORKIN, QUINOX, NRTZ), gastrointestinal products (ABROPAN-D, LAXULOSE, OMEPHEX, RANBRO, PROLAN-D), pain and inflammation treatments (ARCENAC-P, DEFEN, PEMEF), vitamins and supplements (VKAP-D3, CALTON-D, CALTONE-D, ARMEG 4G, OCTAZIN-FORTE, SPORIVIT, GLU-V-PLEX), respiratory products (BRONLUKA-LC, KOSPIN, CETEN, TRINOL-P, ABROHIST), and the proprietary SNEC30 curcumin range (SNEC30, SNEC30 PLUS, SNEC P DROPS, SNEC G ORAL GEL, SNEC30 GARGLE, SNEC30 ALL PURPOSE CREAM). The company also offers regulatory affairs services, in-house R&D, quality control and assurance, and testing services including clinical trials support.

Differentiator

Problem solved

Functional benefit

Brands

• SNEC30: Proprietary Self Nano Emulsifying Curcumin technology with superior bioavailability, developed with DRDO and Jamia Hamdard. Includes oral capsules, drops for kids, oral gel, gargle, moisturizing lotion, body wash, bathing bar, and all-purpose cream.
• Vkap-D3
• Puritol

Products and services

• Tablet Manufacturing High-capacity WHO-GMP compliant tablet manufacturing including coated, uncoated, enteric-coated, effervescent, and sustained-release tablets with automated production lines for pharmaceutical and nutraceutical brand partners.
• Capsule Manufacturing Hard gelatin and HPMC capsule manufacturing for pharmaceutical and nutraceutical brands with precision filling, blending, and packaging in WHO-GMP certified facilities.
• Liquid / Syrup Manufacturing Oral liquids, syrups, suspensions, and elixirs manufactured in cGMP compliant liquid manufacturing units with fully automated filling lines for pharmaceutical brand partners.
• Ointment & Cream Manufacturing Topical formulations including creams, ointments, gels, and lotions manufactured in dedicated sterile areas complying with GMP norms for pharmaceutical and cosmeceutical brand partners.
• Soft Gelatin Capsules Soft gelatin capsule manufacturing for vitamins, fish oil, herbal extracts, and specialty pharma products using precision encapsulation technology for brand partners.
• Dry Syrups & Oral Suspensions Dry syrup and oral suspension manufacturing including antibiotics, pediatric formulations, and specialty products with extended shelf life for pharmaceutical brand partners.
• Nutraceutical Manufacturing FSSAI-compliant nutraceutical and dietary supplement manufacturing covering vitamins, minerals, proteins, and herbal blends in tablets, capsules, sachets, and liquid forms for wellness and supplement brands.
• Herbal & Ayurvedic Manufacturing AYUSH-compliant herbal and Ayurvedic product manufacturing including churna, vati, arka, asava, arishta, and standardized herbal extracts for brand partners needing traditional Indian medicine formulations.
• Cosmeceuticals Manufacturing Cosmeceutical product manufacturing including medicated skincare, derma creams, sun care, and hair care formulations under regulated cGMP conditions, including proprietary two-phase Cosmetic Capsule Cream Technology for active ingredient delivery.
• Hand Sanitizers & Disinfectants Manufacturing WHO-formula compliant hand sanitizer and antiseptic manufacturing in gel, liquid, and foam forms ranging from 100 ml to 5,000 ml bulk packs for retail and institutional brand partners.
• Private Label & OTC Manufacturing Full private-label pharmaceutical manufacturing from formulation development, manufacturing, packaging, and regulatory submissions for client brands across OTC categories, allowing buyer brands to launch under their own label.
• Packaging Solutions End-to-end packaging for pharmaceutical products including blister packing, strip packing, bottle filling, sachet packing, and multi-layer carton packaging offered to brand partners alongside manufacturing.
• Regulatory Affairs Services Product registration, regulatory strategy development, compliance monitoring, and CTD/eCTD dossier preparation and submissions for global markets including CDSCO approvals and WHO PQ dossiers.
• Research & Development Services Formulation development for off-patent medications, analytical research, and innovation services including the US-patented SNEC30 nano-curcumin technology developed in collaboration with DRDO and Jamia Hamdard, supported by a DST-recognized R&D unit.
• Quality Control & Assurance Services NABL-accredited QC laboratory with HPLC, GC, UV-Vis spectrophotometry, dissolution testing, and microbiological analysis complying with US FDA and EU regulations, providing quality oversight from raw materials through distribution.
• Analytical Testing Services Raw material and finished product testing, method validation, stability studies, and water analysis offered through 5 ISO 17025:2017 accredited laboratories including 2 USFDA-inspected and 1 WHO-prequalified facility.
• Clinical Research Services Clinical trial design and execution, real-world evidence studies, pharmacovigilance, BA/BE (bioequivalence) monitoring, and regulatory compliance support for pharmaceutical and herbal products.
• SNEC30 Self Nano Emulsifying Curcumin Range Proprietary US-patented Self Nano Emulsifying Curcumin range (SNEC30 and SNEC30 PLUS 30mg capsules, paediatric SNEC P DROPS, oral gel, gargle, and all-purpose cream) offering superior bioavailability vs. standard curcumin for joint pain, immune support, oral inflammation, skin inflammation, and wound healing.
• Vkap-D3 (Cholecalciferol 60,000 IU) Plant-based, liquid-filled HPMC capsule containing Vitamin D3 60,000 IU launched in August 2022 as a vegetarian/vegan alternative for treatment of Vitamin D deficiency, osteoporosis, rickets, and hypocalcemia.
• AZICIN-250/500 (Azithromycin) Azithromycin 250mg/500mg tablets marketed as a broad-spectrum antibiotic for respiratory tract infections.
• ARLIS-625 (Amoxicillin + Clavulanic Acid) Amoxicillin 500mg + Clavulanic Acid 125mg combination antibiotic tablets indicated for pneumonia, LRTI, URTI, UTI, typhoid, and dental infections.
• Puritol Hand Sanitizer Range WHO-GMP certified hand sanitizer range including Puritol and Puritol-E variants sold in gel, liquid, and foam forms in pack sizes from 100ml to 5,000ml bulk packs.

Quantifiable outcome

• 100% cure rate against atypical respiratory pathogens demonstrated by Azithromycin (AZICIN-250/500) formulation
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core.

• DRDO (Defence Research and Development Organisation)coreStrategic or Co-development PartnerCollaborative development of US-patented nano-curcumin technology (SNEC30). DRDO partnership resulted in proprietary Self Nano Emulsifying Curcumin formulation with superior bioavailability.
• Jamia HamdardcoreStrategic or Co-development PartnerCollaborative development of US-patented nano-curcumin technology (SNEC30). University partnership for advanced pharmaceutical formulations and drug delivery systems research.
• JNU (Jawaharlal Nehru University)coreStrategic or Co-development PartnerCollaborative research on advanced pharmaceutical formulations and drug delivery systems. Ongoing partnerships with prestigious academic and research institutions.
• AIIMS (All India Institute of Medical Sciences)coreStrategic or Co-development PartnerClinical research collaboration with India's premier medical institution. Partnership accelerating development of novel pharmaceutical formulations through clinical research expertise.
• Department of Science and Technology (DST)coreStrategic or Co-development PartnerGovernment-recognized R&D unit with official DST accreditation. Recognition underscores quality and impact of Arbro's research initiatives in pharmaceutical innovation.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Sun Pharmaceutical Industries: India's largest pharmaceutical company with a broad branded generics, API, and contract manufacturing portfolio. Overlaps with Arbro across multiple therapeutic categories and export markets, though Sun operates at vastly greater scale.
• Piramal Pharma Solutions: Global CDMO arm of Piramal Pharma offering integrated drug substance and drug product services. Overlaps with Arbro on formulation contract manufacturing and analytical services but operates at substantially greater scale with worldwide facilities.
• Aurobindo Pharma: Large Indian generic pharmaceutical manufacturer with global operations across formulations and APIs. Comparable to Arbro in generic formulations manufacturing and export orientation, though at much larger scale with broader therapy coverage.
• Cipla: Major Indian multinational pharmaceutical company with a broad portfolio of branded generics and APIs across respiratory, cardiovascular, and other categories. Comparable to Arbro in therapy breadth and Indian-market branded generics focus, but at substantially larger scale with global commercial reach.

Direct peers

• Syngene International: India-listed contract research and manufacturing organisation offering formulation development, manufacturing, and analytical services to global pharma. Comparable to Arbro in the contract manufacturing + testing services model, though significantly larger and more research-led.
• Sai Life Sciences: Indian CRDMO offering drug discovery, development, and manufacturing services. Comparable to Arbro in providing formulation and analytical services to global clients, though more discovery-oriented and larger.
• Neuland Laboratories: Indian API and CDMO manufacturer with USFDA-inspected facilities supplying global pharma. Comparable to Arbro in contract manufacturing focus, regulatory moat, and reliance on export markets.
• Suven Pharma: Indian CDMO providing contract development and manufacturing of formulations and APIs for global innovators. Closely comparable to Arbro's contract manufacturing and CRAMS orientation across multiple dosage forms.
• Divis Laboratories: Indian API and intermediates manufacturer with growing formulations and custom synthesis services. Comparable to Arbro in chemistry-driven manufacturing, regulatory strength, and export-led model, though at meaningfully larger scale.
• Gland Pharma: India-based injectables-focused manufacturer serving global generics and CDMO clients. Comparable to Arbro in CDMO orientation, USFDA-inspected facilities, and export-led business model, though focused on injectables.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/arbro-pharmaceuticals

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arbro Pharmaceuticals